The revitalization of psychedelic substances for therapeutic applications has ignited significant interest in their potential as breakthrough treatments, driving a flurry of research and efforts to introduce these therapies into the market. In the United States, the journey to market for regulated substances is stringent, requiring extensive research, clinical tests, and trials overseen by the…